491 related articles for article (PubMed ID: 28232966)
1. Salivary IgA, Interleukin-1β and MMP-8 as Salivary Biomarkers in Chronic Periodontitis Patients.
Rangbulla V; Nirola A; Gupta M; Batra P; Gupta M
Chin J Dent Res; 2017; 20(1):43-51. PubMed ID: 28232966
[TBL] [Abstract][Full Text] [Related]
2. Periodontitis and Endothelial Dysfunction: Periodontal Clinical Parameters and Levels of Salivary Markers Interleukin-1β, Tumor Necrosis Factor-α, Matrix Metalloproteinase-2, Tissue Inhibitor of Metalloproteinases-2 Complex, and Nitric Oxide.
Moura MF; Navarro TP; Silva TA; Cota LOM; Soares Dutra Oliveira AM; Costa FO
J Periodontol; 2017 Aug; 88(8):778-787. PubMed ID: 28492359
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid arthritis and salivary biomarkers of periodontal disease.
Mirrielees J; Crofford LJ; Lin Y; Kryscio RJ; Dawson DR; Ebersole JL; Miller CS
J Clin Periodontol; 2010 Dec; 37(12):1068-74. PubMed ID: 20880053
[TBL] [Abstract][Full Text] [Related]
4. Salivary interleukin-1β levels in patients with chronic periodontitis before and after periodontal phase I therapy and healthy controls: a case-control study.
Kaushik R; Yeltiwar RK; Pushpanshu K
J Periodontol; 2011 Sep; 82(9):1353-9. PubMed ID: 21235331
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-β in patients with different periodontal diseases.
Toyman U; Tüter G; Kurtiş B; Kıvrak E; Bozkurt Ş; Yücel AA; Serdar M
J Periodontal Res; 2015 Feb; 50(1):44-51. PubMed ID: 24690077
[TBL] [Abstract][Full Text] [Related]
6. Effect of scaling and root planing on interleukin-1β, interleukin-8 and MMP-8 levels in gingival crevicular fluid from chronic periodontitis patients.
Konopka L; Pietrzak A; Brzezińska-Błaszczyk E
J Periodontal Res; 2012 Dec; 47(6):681-8. PubMed ID: 22510045
[TBL] [Abstract][Full Text] [Related]
7. Salivary biomarkers in a biofilm overgrowth model.
Morelli T; Stella M; Barros SP; Marchesan JT; Moss KL; Kim SJ; Yu N; Aspiras MB; Ward M; Offenbacher S
J Periodontol; 2014 Dec; 85(12):1770-8. PubMed ID: 25079398
[TBL] [Abstract][Full Text] [Related]
8. Periodontal parameters and whole salivary cytokine profiles among habitual gutka chewers and non-chewers.
Javed F; Al-Kheraif AA; Al Amri MD; Mikami T; Vohra F; Warnakulasuriya S; Romanos GE
J Periodontol; 2015 May; 86(5):689-95. PubMed ID: 25612632
[TBL] [Abstract][Full Text] [Related]
9. Salivary biomarkers associated with gingivitis and response to therapy.
Syndergaard B; Al-Sabbagh M; Kryscio RJ; Xi J; Ding X; Ebersole JL; Miller CS
J Periodontol; 2014 Aug; 85(8):e295-303. PubMed ID: 24502627
[TBL] [Abstract][Full Text] [Related]
10. Salivary biomarkers of periodontal disease in response to treatment.
Sexton WM; Lin Y; Kryscio RJ; Dawson DR; Ebersole JL; Miller CS
J Clin Periodontol; 2011 May; 38(5):434-41. PubMed ID: 21480939
[TBL] [Abstract][Full Text] [Related]
11. Whole salivary interleukin-6 and matrix metalloproteinase-8 levels in patients with chronic periodontitis with and without prediabetes.
Javed F; Ahmed HB; Saeed A; Mehmood A; Bain C
J Periodontol; 2014 May; 85(5):e130-5. PubMed ID: 24171502
[TBL] [Abstract][Full Text] [Related]
12. Role of salivary matrix metalloproteinase-8 (MMP-8) in chronic periodontitis diagnosis.
Gupta N; Gupta ND; Gupta A; Khan S; Bansal N
Front Med; 2015 Mar; 9(1):72-6. PubMed ID: 25098434
[TBL] [Abstract][Full Text] [Related]
13. Saliva and serum levels of pentraxin-3 and interleukin-1β in generalized aggressive or chronic periodontitis.
Gümüş P; Nizam N; Nalbantsoy A; Özçaka Ö; Buduneli N
J Periodontol; 2014 Mar; 85(3):e40-6. PubMed ID: 23952075
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1beta and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis.
Tüter G; Kurtiş B; Serdar M
J Periodontol; 2001 Jul; 72(7):883-8. PubMed ID: 11495136
[TBL] [Abstract][Full Text] [Related]
15. Salivary Colony Stimulating Factor-1 and Interleukin-34 in Periodontal Disease.
Martinez GL; Majster M; Bjurshammar N; Johannsen A; Figueredo CM; Boström EA
J Periodontol; 2017 Aug; 88(8):e140-e149. PubMed ID: 28474967
[TBL] [Abstract][Full Text] [Related]
16. Salivary Levels of NLRP3 Inflammasome-Related Proteins as Potential Biomarkers of Periodontal Clinical Status.
Isaza-Guzmán DM; Medina-Piedrahíta VM; Gutiérrez-Henao C; Tobón-Arroyave SI
J Periodontol; 2017 Dec; 88(12):1329-1338. PubMed ID: 28691886
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of IL-1β, IL-1ra, and IL-10 levels and outcome of periodontal therapy in chronic periodontitis with familial Mediterranean fever.
Bostanci V; Toker H; Senel S; Poyraz O; Akpinar A; Görgün EP; Bakar O
Clin Oral Investig; 2017 Jan; 21(1):469-475. PubMed ID: 27068409
[TBL] [Abstract][Full Text] [Related]
18. Salivary IL-1β and PGE2 as biomarkers of periodontal status, before and after periodontal treatment.
Sánchez GA; Miozza VA; Delgado A; Busch L
J Clin Periodontol; 2013 Dec; 40(12):1112-7. PubMed ID: 24118119
[TBL] [Abstract][Full Text] [Related]
19. The adjunctive use of systemic antioxidant therapy (lycopene) in nonsurgical treatment of chronic periodontitis: a short-term evaluation.
Arora N; Avula H; Avula JK
Quintessence Int; 2013; 44(6):395-405. PubMed ID: 23479592
[TBL] [Abstract][Full Text] [Related]
20. Salivary biomarkers of bacterial burden, inflammatory response, and tissue destruction in periodontitis.
Salminen A; Gursoy UK; Paju S; Hyvärinen K; Mäntylä P; Buhlin K; Könönen E; Nieminen MS; Sorsa T; Sinisalo J; Pussinen PJ
J Clin Periodontol; 2014 May; 41(5):442-50. PubMed ID: 24460823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
